News
The FDA is considering the approval of the Novavax COVID-19 booster after delays amid controversy over its non-mRNA design.
An ivonescimab-chemotherapy combination succeeded in a study in China. Elsewhere, the FDA asked Novavax for more COVID ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results